Pharmacokinetic Individualisation of Zidovudine Therapy
- 1 April 1996
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 30 (4) , 314-327
- https://doi.org/10.2165/00003088-199630040-00004
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- Prolonged, But Not Diminished, Zidovudine Absorption Induced by a High‐Fat BreakfastPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1994
- Quantitative relationships between zidovudine exposure and efficacy and toxicityAntimicrobial Agents and Chemotherapy, 1994
- Effects of standard breakfast on pharmacokinetics of oral zidovudine in patients with AIDSAntimicrobial Agents and Chemotherapy, 1993
- Azidothymidine-induced cytotoxicity and incorporation into DNA in the human colon tumor cell line HCT-8 is enhanced by methotrexate in vitro and in vivo.1992
- Pharmacokinetics of Zidovudine Phosphorylation in Patients Infected with the Human Immunodeficiency VirusTherapeutic Drug Monitoring, 1992
- Combination Therapy with Zidovudine and Dideoxycytidine in Patients with Advanced Human Immunodeficiency Virus InfectionAnnals of Internal Medicine, 1992
- Decreased and variable systemic availability of zidovudine in patients with AIDS if administered with a mealEuropean Journal of Clinical Pharmacology, 1991
- Pharmacokinetics of zidovudine in patients with liver cirrhosisClinical Pharmacology & Therapeutics, 1990
- Pharmacokinetics and bioavailability of zidovudine in humans.1988
- The in vitro and in vivo anti-retrovirus activity, and intracellular metabolism of 3′-azido-2′,3′-dideoxythymidine and 2′,3′-dideoxycytidine are highly dependent on the cell speciesBiochemical Pharmacology, 1988